0002031964-24-000001.txt : 20240802 0002031964-24-000001.hdr.sgml : 20240802 20240802151934 ACCESSION NUMBER: 0002031964-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240802 DATE AS OF CHANGE: 20240802 EFFECTIVENESS DATE: 20240802 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NILO Therapeutics, Inc. CENTRAL INDEX KEY: 0002031964 ORGANIZATION NAME: IRS NUMBER: 992175125 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-520504 FILM NUMBER: 241170526 BUSINESS ADDRESS: STREET 1: 1 LETTERMAN DRIVE STREET 2: BUILDING D, SUITE DM-900 CITY: SAN FRANCISCO STATE: CA ZIP: 94129 BUSINESS PHONE: 415-865-2050 MAIL ADDRESS: STREET 1: 1 LETTERMAN DRIVE STREET 2: BUILDING D, SUITE DM-900 CITY: SAN FRANCISCO STATE: CA ZIP: 94129 D 1 primary_doc.xml X0708 D LIVE 0002031964 NILO Therapeutics, Inc. 430 E 29th St, Suite 625 New York NY NEW YORK 10016 415-865-2050 DELAWARE None None Corporation true 2024 Tim Kutzkey 430 E 29th St, Suite 625 New York NY NEW YORK 10016 Executive Officer Director Promoter Jeff Goater 430 E 29th St, Suite 625 New York NY NEW YORK 10016 Executive Officer Director Biotechnology Decline to Disclose 06b false 2024-07-18 false true true false 0 101000002 9600002 91400000 false 3 0 0 0 false NILO Therapeutics, Inc. /s/ Jeff Goater Jeff Goater Chief Financial Officer 2024-08-02